118 related articles for article (PubMed ID: 17397920)
1. Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.
Cervetti G; Carulli G; Galimberti S; Azzarà A; Cannizzo E; Buda G; Orciuolo E; Petrini M
Leuk Res; 2008 Jan; 32(1):191-2. PubMed ID: 17397920
[No Abstract] [Full Text] [Related]
2. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
[TBL] [Abstract][Full Text] [Related]
3. Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
Cervetti G; Carulli G; Galimberti S; Azzarà A; Buda G; Orciuolo E; Pelosini M; Petrini M
Leuk Res; 2008 Jan; 32(1):194-5. PubMed ID: 17459473
[No Abstract] [Full Text] [Related]
4. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
5. Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.
Khouri S; Kotliroff A; Lishner M; Amital H
Isr Med Assoc J; 2008 Apr; 10(4):320-1. PubMed ID: 18548994
[No Abstract] [Full Text] [Related]
6. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Woo SM; Huh CH; Park KC; Youn SW
J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148
[No Abstract] [Full Text] [Related]
7. Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.
Ferrand H; Tamburini J; Mouly S; Bouscary D; Bergmann JF
Clin Infect Dis; 2005 Dec; 41(11):1684-5. PubMed ID: 16267747
[No Abstract] [Full Text] [Related]
8. Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib.
Franceschino A; Tornaghi L; Benemacher V; Assouline S; Gambacorti-Passerini C
Haematologica; 2008 Feb; 93(2):317-8. PubMed ID: 18245661
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis.
Campiotti L; Codari R; Appio L; Ultori C; Solbiati F; Maria Grandi A; Venco A
Leuk Res; 2007 Dec; 31(12):1768-70. PubMed ID: 17403537
[No Abstract] [Full Text] [Related]
10. Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.
Rosado MF; Donna E; Ahn YS
J Clin Oncol; 2003 Aug; 21(16):3171-3. PubMed ID: 12915610
[No Abstract] [Full Text] [Related]
11. Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy.
Dib EG; Ifthikharuddin JJ; Scott GA; Partilo SR
Leuk Res; 2005 Feb; 29(2):233-4. PubMed ID: 15607374
[No Abstract] [Full Text] [Related]
12. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
Ramasamy K; Hayden J; Lim Z; Mufti GJ; Ho AY
Br J Haematol; 2007 May; 137(4):374-5. PubMed ID: 17408403
[No Abstract] [Full Text] [Related]
13. Prolonged imatinib-induced myelosuppression in chronic myeloid leukaemia with an unusually long survival.
Busuttil DP
Int J Lab Hematol; 2008 Feb; 30(1):68-70. PubMed ID: 18190471
[TBL] [Abstract][Full Text] [Related]
14. Irreversible sensorineural hearing loss due to Imatinib.
Attili VS; Bapsy PP; Anupama G; Lokanatha D
Leuk Res; 2008 Jun; 32(6):991-2. PubMed ID: 18221994
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of colon adenocarcinoma in chronic myeloid leukemia patients treated with imatinib: report of two cases and review of the literature.
Frustaci A; Breccia M; Cannella L; Stefanizzi C; Alimena G
Leuk Res; 2009 Jan; 33(1):200-1. PubMed ID: 18452989
[No Abstract] [Full Text] [Related]
16. Tumour lysis syndrome with acute renal failure during imatinib therapy.
Ali R; Ozkalemkas F; Ozkan A; Ozcelik T; Ozkocaman V; Akdag I; Ozan U; Tunali A
Leuk Res; 2007 Apr; 31(4):573-4. PubMed ID: 16782190
[No Abstract] [Full Text] [Related]
17. Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: A single institution experience.
Breccia M; Cannella L; Frustaci A; Stefanizzi C; Levi A; Alimena G
Leuk Res; 2008 May; 32(5):835-6. PubMed ID: 17905431
[No Abstract] [Full Text] [Related]
18. [Generalized erythema triggered by a rapid decrease of basophils in chronic myeloid leukemia treated with imatinib].
Sugito M; Tsukada J; Higashi T; Ohta T; Matsuura A; Kubota A; Mizobe T; Mouri F; Morimoto H; Tanaka Y
Rinsho Ketsueki; 2005 Nov; 46(11):1226-8. PubMed ID: 16440809
[TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
[TBL] [Abstract][Full Text] [Related]
20. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
